======= PLCD1 =======
== Gene Information ==
* **Official Symbol**: PLCD1
* **Official Name**: phospholipase C delta 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5333|5333]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P51178|P51178]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PLCD1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLCD1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602142|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the phospholipase C family. Phospholipase C isozymes play critical roles in intracellular signal transduction by catalyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into the second messengers diacylglycerol (DAG) and inositol triphosphate (IP3). The encoded protein functions as a tumor suppressor in several types of cancer, and mutations in this gene are a cause of hereditary leukonychia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].
* **UniProt Summary**: The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. Essential for trophoblast and placental development.
|PI-PLC-Y|
|C2|
|PI-PLC-X|
|efhand like|
|GTPase activating protein binding|
|inositol trisphosphate biosynthetic process|
|labyrinthine layer blood vessel development|
|inositol trisphosphate metabolic process|
|phosphatidylinositol phospholipase C activity|
|inositol phosphate biosynthetic process|
|placenta blood vessel development|
|labyrinthine layer development|
|inositol phosphate metabolic process|
|polyol biosynthetic process|
|phosphatidylinositol-4,5-bisphosphate binding|
|embryonic placenta development|
|polyol metabolic process|
|alcohol biosynthetic process|
|placenta development|
|organic hydroxy compound biosynthetic process|
|lipid catabolic process|
|angiogenesis|
|alcohol metabolic process|
|phospholipid metabolic process|
|in utero embryonic development|
|blood vessel morphogenesis|
|reproductive structure development|
|reproductive system development|
|embryonic organ development|
|organic hydroxy compound metabolic process|
|blood vessel development|
|vasculature development|
|cardiovascular system development|
|organophosphate biosynthetic process|
|small molecule biosynthetic process|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|tube morphogenesis|
|developmental process involved in reproduction|
|calcium ion binding|
|tube development|
|circulatory system development|
|organophosphate metabolic process|
|anatomical structure formation involved in morphogenesis|
|cellular lipid metabolic process|
|embryo development|
|lipid metabolic process|
|reproductive process|
|reproduction|
|regulation of cell population proliferation|
|intracellular signal transduction|
|small molecule metabolic process|
|organic substance catabolic process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5465
* **Expression level (log2 read counts)**: 1.83
{{:chemogenomics:nalm6 dist.png?nolink |}}